Many of the cytokines involved in LN and other autoimmune diseases, including IL-17, signal through receptors associated with JAKs, and CP-690,550 targets JAK3, which plays a pivotal role in the beginning of the inflammatory cytokine signaling pathway. This evidence concerns the gene IL17A and autoimmune disease.